2012 annual financial data
Altimmune 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -9.23%.
Operating income was -6,266,390 USD and net income was -4,920,115 USD.
Operating cash flow was -2,322,906 USD.
Get free Altimmune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,175,887 USD
- Operating income
- -6,266,390 USD
- Net income
- -4,920,115 USD
- Operating cash flow
- -2,322,906 USD